Want to join the conversation?
Biotech company $ACOR said it has signed a merger agreement with Biotie Therapies, a Finnish biotech company, pursuant to which $ACOR will make a public tender offer in Finland and in US to acquire all shares, stock options, and warrants in Biotie, not owned by Biotie or its subsidiaries. The offer period is expected to start by mid-March 2016.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!